Healthcare and Life Sciences Are Converging. Is Your Platform’s Technology Ready for Diligence?

Healthcare and Life Sciences Are Converging. Is Your Platform’s Technology Ready for Diligence? For years, Healthcare and Life Sciences were treated as adjacent but distinct diligence categories, with different regulatory requirements, buyer profiles, and technology environments. Healthcare diligence focused on HIPAA, interoperability, and the patient record. Life Sciences diligence focused on GxP, validation, and the […]
Continue Reading

A Longer Hold Period Isn’t Extra Time to Wait. It’s Extra Time to Create Value.

With hold periods extending, private equity firms have more time to focus on what they can control: creating value within the portfolio. Technology is increasingly part of that equation. From scalability and technical debt to AI readiness and data, the hold period is an opportunity to strengthen Quality of Tech (QoT™) and better support the investment thesis.
Continue Reading

What Separates Portfolio Companies That Scale From Those That Stall

Private equity firms invest significant time developing value creation plans, but execution depends on more than strategy alone. As portfolio companies grow, the quality of their technology increasingly determines how effectively they can scale, integrate acquisitions, improve operations, and create enterprise value. This article explores why Quality of Tech (QoT™) has become a critical factor in investment success.
Continue Reading

IT Ally®, LLC

IT Ally® advises Lower Middle Market private equity firms, family offices, and independent sponsors on transforming technology from a hidden operational risk into a powerful Valuation Multiplier.

Powered by our proprietary Quality of Tech (QoT ™ ) methodology, we provide investor-grade diligence and execution that quantify tech debt, accelerate integration velocity, and engineer lasting equity from buy to sell.

Categories

Latest Posts

Get Actionable Insights

Subscribe to IT Ally® Insights for sponsor-grade perspectives on technology, enterprise value, operational risk, and value creation across the investment lifecycle.

Get updates on QoT™, private equity trends, transaction advisory, and technology strategies shaping lower middle market platforms.